Concepedia

R. Clemmer

RC

3

Publications

164

Citations

3

H-Index

2012

Active since

Affiliations

Pfizer (United States)(Current)

Université Claude Bernard Lyon 1

University Health System

Virginia Commonwealth University

R. Clemmer is an author at Pfizer (United States) specializing in health sciences, osteoarthritis, and musculoskeletal imaging.

Top concepts

Publications per year

2012–2014

3

Publications

3

A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee

Marie‐Pierre Hellio Le Graverand, R. Clemmer, Patricia Redifer et al. · Annals of the Rheumatic Diseases · 2012 · 131 citations

Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography

Marie‐Pierre Hellio Le Graverand, R. Clemmer, Robert Brunell et al. · Seminars in Arthritis and Rheumatism · 2013 · 19 citations

, , +6

A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain

Samir Arora, Beatrice Setnik, M. Drass et al. · Journal of Opioid Management · 2014 · 14 citations

Rows per page

1–3 of 3